Further, in luminal breast cancers, again about half express CREB3L1, that in lower grade tumors is typically nuclear, where it could regulate transcriptional targets, and in higher grade tumors is typically cytoplasmic, where it could not. Here, CREB3L1 is linked to breast carcinoma.